The projected effect of risk factor reduction on Alzheimer's disease prevalence
- 30 September 2011
- journal article
- review article
- Published by Elsevier BV in The Lancet Neurology
- Vol. 10 (9), 819-828
- https://doi.org/10.1016/s1474-4422(11)70072-2
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Association of Plasma β-Amyloid Level and Cognitive Reserve With Subsequent Cognitive DeclineJAMA, 2011
- Docosahexaenoic Acid Supplementation and Cognitive Decline in Alzheimer DiseaseJAMA, 2010
- Age differences in the prevalence and co-morbidity of DSM-IV major depressive episodes: results from the WHO World Mental Health Survey InitiativeDepression and Anxiety, 2009
- Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer DiseaseA Randomized Controlled TrialJAMA, 2009
- Midlife and Late-Life Obesity and the Risk of DementiaArchives of Neurology, 2009
- Measures of Adiposity and Dementia Risk in Elderly PersonsArchives of Neurology, 2007
- Mediterranean Diet, Alzheimer Disease, and Vascular MediationArchives of Neurology, 2006
- Depression and Risk for Alzheimer DiseaseArchives of General Psychiatry, 2006
- Depressive Symptoms, Vascular Disease, and Mild Cognitive ImpairmentArchives of General Psychiatry, 2006
- The Metabolic Syndrome, Inflammation, and Risk of Cognitive DeclineJAMA, 2004